Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Garcia

Showing results (301-310 of 455) with videos related to

Pageof 46
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 9, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026Yoshiki Sekijima, Mitsuharu Ueda, John L Berk, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 9, 2023
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factorPablo Garcia-Manau, Erika Bonacina, Berta Serrano, et al.
Heart Rhythm|February 17, 2020
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5Fernando Dominguez, Esther Zorio, Juan Jimenez-Jaimez, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2018
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKTSaravanan Parthasarathy, Kenneth Henry, Huaxing Pei, et al.
Journal of Clinical Medicine|June 24, 2022
Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 PatientsRickard Lagedal, Oskar Eriksson, Anna Sörman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2022
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in SpainFernando de Frutos, Juan Pablo Ochoa, Cristina Gómez-González, et al.
Circulation. Genomic and Precision Medicine|November 5, 2020
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European RegistryDor Lotan, Joel Salazar-Mendiguchía, Jens Mogensen, et al.
Redox Biology|November 27, 2016
Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C diseaseSandra Torres, Nuria Matías, Anna Baulies, et al.
Scientific Reports|August 4, 2021
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patientsJoram Huckriede, Sara Bülow Anderberg, Albert Morales, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Pageof 46

Showing results (301-310 of 455) with videos related to

Sort By:
Pageof 46
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 9, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026Yoshiki Sekijima, Mitsuharu Ueda, John L Berk, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 9, 2023
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factorPablo Garcia-Manau, Erika Bonacina, Berta Serrano, et al.
Heart Rhythm|February 17, 2020
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5Fernando Dominguez, Esther Zorio, Juan Jimenez-Jaimez, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2018
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKTSaravanan Parthasarathy, Kenneth Henry, Huaxing Pei, et al.
Journal of Clinical Medicine|June 24, 2022
Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 PatientsRickard Lagedal, Oskar Eriksson, Anna Sörman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 7, 2022
Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in SpainFernando de Frutos, Juan Pablo Ochoa, Cristina Gómez-González, et al.
Circulation. Genomic and Precision Medicine|November 5, 2020
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European RegistryDor Lotan, Joel Salazar-Mendiguchía, Jens Mogensen, et al.
Redox Biology|November 27, 2016
Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C diseaseSandra Torres, Nuria Matías, Anna Baulies, et al.
Scientific Reports|August 4, 2021
Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patientsJoram Huckriede, Sara Bülow Anderberg, Albert Morales, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK's first real-world experienceJoana Moniz Dionísio, Philip Ambrose, Georgina Burke, et al.
Pageof 46